290
Participants
Start Date
April 1, 2018
Primary Completion Date
December 26, 2020
Study Completion Date
March 30, 2021
Morphine
Morphine group will receive intrathecal 11 mg of hyperbaric bupivacaine (2.2 mL 0.5%), 10 μg of fentanyl (0.2 ml) and 100 μg of preservative free morphine (0.1 ml).
Placebo
Placebo group will receive 11 mg of hyperbaric bupivacaine (2.2 mL 0.5%), 10 μg of fentanyl (0.2 ml) and normal saline (0.1ml)
BP Koirala Institute of Health Sciences (BPKIHS), Dharān
B.P. Koirala Institute of Health Sciences
OTHER